Hematopoietic stem cell transplantation (HSCT) has become a cornerstone in the management of various haematological malignancies and non-malignant disorders. Central to this therapeutic approach is ...
Neurological complications after allogeneic hematopoietic cell transplantation (alloHCT) have been reported with a varying incidence between 8% and 42% in bone marrow recipients. 1 Among this type of ...